SAR of non-hydrolysable analogs of pyridoxal 5′-phosphate against low molecular weight protein tyrosine phosphatase isoforms
- 10 June 2020
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 30 (16), 127342
- https://doi.org/10.1016/j.bmcl.2020.127342
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Identification of new inhibitors for low molecular weight protein tyrosine phosphatase isoform BBioorganic & Medicinal Chemistry Letters, 2013
- The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesisTumor Biology, 2013
- Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targets for the Design of Novel Therapeutic AgentsJournal of Medicinal Chemistry, 2011
- Identification of novel inhibitors for a low molecular weight protein tyrosine phosphatase via virtual screeningBioorganic & Medicinal Chemistry, 2010
- The interplay of structural information and functional studies in kinase drug design: insights from BCR-AblCurrent Opinion in Cell Biology, 2009
- Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancersBiochemical and Biophysical Research Communications, 2005
- Reaction specificity in pyridoxal phosphate enzymesArchives of Biochemistry and Biophysics, 2005
- Pyridoxal Phosphate Enzymes: Mechanistic, Structural, and Evolutionary ConsiderationsAnnual Review of Biochemistry, 2004
- Structural Basis of the Tight Binding of Pyridoxal 5‘-Phosphate to a Low Molecular Weight Protein Tyrosine Phosphatase†Biochemistry, 1999
- The Molecular Basis of the Differing Kinetic Behavior of the Two Low Molecular Mass Phosphotyrosine Protein Phosphatase IsoformsOnline Journal of Public Health Informatics, 1996